Comparison of guidelines on rectal cancer:exception proves the rule?  

直肠癌指南对比:例外反证规则?

作　　者：Ruoxu Dou Siqi He Yanhong Deng Jianping Wang 

机构地区：[1]Department of Colorectal Surgery,The Sixth Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,P.R.China [2]Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases,The Sixth Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,P.R.China [3]Department of Medical Oncology,The Sixth Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,P.R.China [4]Department of Gastrointestinal Surgery,Foresea Life Insurance Guangzhou General Hospital,Guangzhou,Guangdong,P.R.China

出　　处：《Gastroenterology Report》2021年第4期290-298,I0001,共10页胃肠病学报道（英文）

摘　　要：The standard of care for early or locally advanced rectal cancer is promoted by multiple clinical practice guidelines globally,but the considerable differences between the guidelines may cause confusion.We compared the latest updated clinical practice guidelines from five professional societies/authorities:National Comprehensive Cancer Network,American Society of Colorectal Surgeons,European Society of Medical Oncology,Chinese National Health Commission,and Chinese Society of Clinical Oncology.Key evidence is discussed for a better understanding of some seemingly contradictory recommendations.临床实践指南正在全球范围内推动着早期或局部进展期直肠癌的治疗规范,但不同指南间的巨大差异也造成了认识上的混乱。我们比较了5个来自专业协会/机构的最新临床实践指南:美国国立综合癌症网络(NCCN)、美国结直肠外科医师学会(ASCRS)、欧洲肿瘤内科学会(ESMO)、中国国家卫生健康委员会(NHC)及中国临床肿瘤学会(CSCO)。本文对一些造成差异的关键证据进行了梳理,以帮助读者更好地理解一些看似矛盾的指南推荐。

关 键 词：clinical practice guideline rectal cancer early or locally advanced comparative study 

分 类 号：R735.37[医药卫生—肿瘤]